Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
RATIONALE: Understanding how well patients comply with their treatment regimen may help doctors determine best treatment and ongoing care for future patients.
PURPOSE: This phase I study is looking at compliance with vaginal dilation therapy in women who have undergone radiation therapy for stage IB, stage IIA, stage IIB, stage IIIA, or stage IIIB cervical cancer or stage IA, stage IB, stage IIA, or stage IIB endometrial cancer.
OBJECTIVES:
Primary
OUTLINE: Patients from the IMPAC registry in Radiation Oncology at the University Hospitals Case Medical Center, Ireland Cancer Center complete questionnaires online or by mail. Questionnaires include the Vaginal Dilation Adherence questionnaire, the Sexual Function-Vaginal Changes Questionnaire, the Dyadic Satisfaction questionnaire, and the Physician/Nurse Recommendation of Vaginal Dilation questionnaire.
DISEASE CHARACTERISTICS:
History of early-stage IB grade 2-IIIB cervical cancer or stage IA grade 3-IIB endometrial cancer
Meets the following criteria:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Cleveland, Ohio 44106-5065, United States